Sponge-on-a-string test for oesophageal cancer could reach more patients with persistent indigestion

No diagnostic test, endoscopy included, identifies every case.
NICE cautions that an all-clear sponge test does not end long-term monitoring.
Mark

So what's actually changing here? The test already exists.

Mimi

It does, in some places. The draft guidance would have it offered across England, to some people with bad, persistent indigestion, and done in a GP surgery rather than a hospital.

Mark

Why does the setting matter so much?

Mimi

Endoscopy needs a camera and hospital capacity, and demand for it is high. The sponge test takes minutes and is less invasive, so it could ease that pressure.

Luke

Worth saying it's a draft. Nothing is settled until NICE publishes final recommendations in the new year.

Mark

And what's the underlying worry for patients?

Mimi

Barrett's oesophagus, where cells in the gullet lining change. It's thought to affect one to two in every 100 adults, and it raises long-term cancer risk.

Luke

But most people with it won't develop cancer. And that one-to-two-in-100 figure is described as what's thought, not a firm count.

Mark

Some people aren't being checked as often as recommended, right?

Mimi

Yes, because endoscopy demand is so high. The sponge test is meant to help close that gap.

Luke

NHS England says thousands have benefited from pilots, but the reporting gives no detection figures, so we can't judge how well it performs.

Mark

Is a clear result the end of it?

Mimi

No. NICE says no test catches every case, so people with an all-clear should still be monitored long term.

  • A swallowed capsule and a pull on a thread could soon screen people with persistent indigestion for oesophageal cancer in ordinary GP surgeries.
  • Endoscopy demand is so high that some people with Barrett's oesophagus are not being checked as often as recommended, creating real pressure on the system.
  • NHS England's pilots have already helped thousands, and national roll-out is now under consideration in draft form.
  • Officials stress that no test catches every case, so a negative sponge result still requires long-term monitoring.
  • Final NICE recommendations are due in the new year, and they will decide how fast the test spreads from pilots to standard care.

In the quiet rooms of an English GP surgery, a small capsule on a thread may soon become a familiar step for people whose stomachs have troubled them for too long. Draft guidance from NICE, the body that sets standards for the NHS, proposes offering this quick sponge test to those with persistent indigestion, so that a condition that quietly alters the lining of the gullet can be noticed sooner. It is a modest procedure, yet it speaks to a larger human effort: finding the few who need closer care without sending the many through more demanding examinations. The final word will come in the new year, and until then the test stands as a promise that is still being weighed.

A patient sits in a GP surgery and swallows a small dissolving capsule tied to a thread. Once it reaches the stomach, it releases a tiny sponge, and when the doctor gently draws the thread back, the sponge collects cells from the lining of the gullet on its way out. The whole process takes minutes, far less than a hospital endoscopy with its camera.

The draft guidance from the National Institute for Health and Care Excellence would see people with bad, persistent indigestion offered this test across England. The reason lies in Barrett's oesophagus, a condition in which cells lining the gullet begin to change, often alongside heartburn or acid reflux. Between one and two adults in every hundred are thought to have it, and while most will never develop cancer, the risk rises over time. Endoscopy capacity is stretched, so some patients are not being checked as often as they should be.

NHS England's national clinical director for cancer, Prof Peter Johnson, said thousands have already benefited from pilots and welcomed the prospect of national roll-out, saying an easier check could free resources to catch cancers earlier. NICE is equally clear that no test is perfect, and anyone reassured by a clear result still needs long-term follow-up.

The guidance remains a draft. Final recommendations are expected in the new year, and they will shape how soon the sponge test becomes routine for people living with persistent reflux.

A patient sits in a GP surgery, swallows a small capsule attached to a thread, and within minutes the test is essentially done. That is the procedure the National Institute for Health and Care Excellence (NICE) now wants to see offered much more widely in England, under new draft guidance for the NHS.

The guidance recommends that some people with bad and persistent indigestion should be offered what is commonly called the sponge-on-a-string test, a check for oesophageal cancer. Unlike endoscopy, which uses a small camera to look inside the body and is done in hospitals, the sponge test can be carried out in a GP surgery and is less invasive. It is already available in some places, but the draft guidance points toward offering it across England.

The mechanics are simple. The patient swallows a small dissolving capsule attached to a thread. Once it reaches the stomach, the capsule releases a tiny sponge. The doctor then gently pulls the thread so the sponge comes back out through the mouth, collecting cells from the lining of the gullet on the way. Those cells are then analysed.

The background is a condition called Barrett's oesophagus, which can accompany heartburn or acid reflux. In it, cells in the lining of the gullet have started to change, and over the long term the risk of cancer rises. It is thought that between one and two adults in every 100 have it. Most of them will not go on to develop cancer, but the demand for NHS endoscopy is high, and as a result some people with the condition are not being checked as often as recommended. NICE says the sponge tests could help give more patients peace of mind.

Prof Jonathan Benger, NICE's chief executive, described the sponge test as a quick and less invasive way of detecting concerning changes, and of identifying who should go on to further tests and treatment. The test can help detect both oesophageal cancer and Barrett's oesophagus in people with reflux disease.

Prof Peter Johnson, national clinical director for cancer at NHS England, said thousands of people have already benefited from the test through pilots the NHS has been running, and called it fantastic that national roll-out is being considered. He added that many people have acid reflux, and that an easier way to check for changes in the oesophageal lining could make a big difference to patients. It could also reduce the need for more complicated endoscopy tests, he said, helping the NHS free up resources to find cancers at an earlier stage.

NICE is careful about the limits. No diagnostic test, endoscopy included, identifies every case, and people who receive an all-clear from a sponge test should still be monitored in the long term.

The guidance is still a draft. NICE will make its final recommendations in the new year, and that decision will determine how quickly the test moves from pilots and some local services to standard practice for people with persistent reflux.

Sponge tests offer a quick and less invasive way to detect concerning changes.
— Prof Jonathan Benger, chief executive of NICE
Thousands have already benefited from this incredibly efficient test through pilots.
— Prof Peter Johnson, national clinical director for cancer, NHS England
Want the full story? Read the original at BBC ↗
Contact Us FAQ